High-Risk Skin Cancers With Atezolizumab Plus NT-I7

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03901573

Recruitment Status : Terminated (Strategic decision by sponsor)

First Posted : April 3, 2019

Last Update Posted : February 22, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

Immune Oncology Network

Information provided by (Responsible Party):

NeoImmuneTech

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	August 15, 2023
Actual Study Completion Date :	August 15, 2023

To Top